D-0190-2016 Class II Terminated

Recalled by The Compounder — Aurora, IL

FDA drug recall D-0190-2016 was initiated by The Compounder on Mar 10, 2015 and is designated Class II. Reason for recall: Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination. The recall status is terminated (terminated May 19, 2016). Affected quantity: 5 (3mL) syringes.

Recall Details

Product Type
Drugs
Report Date
Nov 18, 2015
Initiation Date
Mar 10, 2015
Termination Date
May 19, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 (3mL) syringes

Product Description

BIEST TD 80/20 (Estradiol USP Micronized (E2)/Estriol USP Micronized (E3)) W/V (weight /volume) 8 MG/ML transdermal cream, dispensed in 3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Reason for Recall

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Distribution Pattern

Nationwide

Code Information

Lot # 01232015:75@4, Exp 7/22/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0190-2016
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.